Minilik Angagaw

Minilik Angagaw

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4387816
-
person_outline Minilik Angagaw's MOST POPULAR ARTICLES
1-) Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsEJ Morris, S Jha, CR Restaino, P Dayananth, H Zhu, A Cooper, D Carr, ...Cancer discovery 3 (7), 742-750, 20136202013
2-) Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancerW Zhang, J Zhu, CL Efferson, C Ware, J Tammam, M Angagaw, J Laskey, ...Cancer research 69 (18), 7466-7472, 2009912009
3-) Down‐regulation of the Notch pathway mediated by a γ‐secretase inhibitor induces anti‐tumour effects in mouse models of T‐cell leukaemiaJ Tammam, C Ware, C Efferson, J O\\\'neil, S Rao, X Qu, J Gorenstein, ...British journal of pharmacology 158 (5), 1183-1195, 2009822009
4-) MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRN Booher, H Hatch, BM Dolinski, T Nguyen, L Harmonay, AS Al-Assaad, ...PloS one 9 (10), e108371, 2014632014
5-) A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse modelsBB Haines, KA Bettano, M Chenard, RS Sevilla, C Ware, MH Angagaw, ...Neoplasia 11 (1), 39-47, 2009522009